These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 32196440)

  • 21. Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation.
    Lee SY; Jeong EK; Ju MK; Jeon HM; Kim MY; Kim CH; Park HG; Han SI; Kang HS
    Mol Cancer; 2017 Jan; 16(1):10. PubMed ID: 28137309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The challenge of targeting cancer stem cells to halt metastasis.
    Agliano A; Calvo A; Box C
    Semin Cancer Biol; 2017 Jun; 44():25-42. PubMed ID: 28323021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer stem cell (CSC) resistance drivers.
    Najafi M; Mortezaee K; Majidpoor J
    Life Sci; 2019 Oct; 234():116781. PubMed ID: 31430455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emodin reduces Breast Cancer Lung Metastasis by suppressing Macrophage-induced Breast Cancer Cell Epithelial-mesenchymal transition and Cancer Stem Cell formation.
    Liu Q; Hodge J; Wang J; Wang Y; Wang L; Singh U; Li Y; Yao Y; Wang D; Ai W; Nagarkatti P; Chen H; Xu P; Murphy EA; Fan D
    Theranostics; 2020; 10(18):8365-8381. PubMed ID: 32724475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer stem cell niche models and contribution by mesenchymal stroma/stem cells.
    Melzer C; von der Ohe J; Lehnert H; Ungefroren H; Hass R
    Mol Cancer; 2017 Feb; 16(1):28. PubMed ID: 28148265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential Anti-metastasis Natural Compounds for Lung Cancer.
    Chanvorachote P; Chamni S; Ninsontia C; Phiboonchaiyanan PP
    Anticancer Res; 2016 Nov; 36(11):5707-5717. PubMed ID: 27793892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural products targeting cancer stem cells: Implications for cancer chemoprevention and therapeutics.
    Gairola K; Gururani S; Bahuguna A; Garia V; Pujari R; Dubey SK
    J Food Biochem; 2021 Jul; 45(7):e13772. PubMed ID: 34028051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stem cell programs in cancer initiation, progression, and therapy resistance.
    Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
    Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer stem cells: Role in tumor growth, recurrence, metastasis, and treatment resistance.
    Chang JC
    Medicine (Baltimore); 2016 Sep; 95(1 Suppl 1):S20-S25. PubMed ID: 27611935
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer stem cells in head and neck squamous cell carcinoma: a review.
    Satpute PS; Hazarey V; Ahmed R; Yadav L
    Asian Pac J Cancer Prev; 2013; 14(10):5579-87. PubMed ID: 24289547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanoparticle Delivery of TWIST Small Interfering RNA and Anticancer Drugs: A Therapeutic Approach for Combating Cancer.
    Glackin CA
    Enzymes; 2018; 44():83-101. PubMed ID: 30360816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis.
    Marquardt S; Solanki M; Spitschak A; Vera J; Pützer BM
    Semin Cancer Biol; 2018 Dec; 53():90-109. PubMed ID: 29966677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer stem cell heterogeneity: origin and new perspectives on CSC targeting.
    Eun K; Ham SW; Kim H
    BMB Rep; 2017 Mar; 50(3):117-125. PubMed ID: 27998397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The cancer stem cell phenotype as a determinant factor of the heterotypic nature of breast tumors.
    Fonseca NA; Cruz AF; Moura V; Simões S; Moreira JN
    Crit Rev Oncol Hematol; 2017 May; 113():111-121. PubMed ID: 28427501
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer stem cell immunology and immunotherapy: Harnessing the immune system against cancer's source.
    Ruiu R; Tarone L; Rolih V; Barutello G; Bolli E; Riccardo F; Cavallo F; Conti L
    Prog Mol Biol Transl Sci; 2019; 164():119-188. PubMed ID: 31383404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigenetic and metabolic regulation of breast cancer stem cells.
    Liu HX; Li XL; Dong CF
    J Zhejiang Univ Sci B; 2015 Jan; 16(1):10-7. PubMed ID: 25559951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical translation for endometrial cancer stem cells hypothesis.
    Carvalho MJ; Laranjo M; Abrantes AM; Torgal I; Botelho MF; Oliveira CF
    Cancer Metastasis Rev; 2015 Sep; 34(3):401-16. PubMed ID: 26224131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Designing precision medicine panels for drug refractory cancers targeting cancer stemness traits.
    Warrier S; Patil M; Bhansali S; Varier L; Sethi G
    Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188475. PubMed ID: 33188876
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lung cancer stem cells: tumor biology and clinical implications.
    Nurwidya F; Murakami A; Takahashi F; Takahashi K
    Asia Pac J Clin Oncol; 2012 Sep; 8(3):217-22. PubMed ID: 22897822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metastatic cancer stem cells: new molecular targets for cancer therapy.
    Leirós GJ; Balañá ME
    Curr Pharm Biotechnol; 2011 Nov; 12(11):1909-22. PubMed ID: 21470128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.